Expand BIAF Menu
BIAF MENU

BIAF Latest Press Releases

-- September 3, 2026 --

bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference Business Wire 4:30 PM

-- September 1, 2026 --

bioAffinity Technologies Advances CyPath Lung for Surveillance of Lung Cancer Survivors Business Wire 8:00 AM

-- August 20, 2026 --

bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026 Business Wire 8:00 AM

-- August 18, 2026 --

bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath Lung Business Wire 8:00 AM

-- August 14, 2026 --

WallachBeth Capital Announces Closing of bioAffinity Technologies $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules PRNewswire 11:45 AM
bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules Business Wire 11:07 AM

-- August 13, 2026 --

WallachBeth Capital Announces bioAffinity Technologies Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules PRNewswire 10:01 AM
bioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules Business Wire 9:07 AM

-- August 7, 2026 --

bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath Lung Business Wire 8:00 AM

-- July 27, 2026 --

bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath Lung Business Wire 8:08 AM

-- July 22, 2026 --

bioAffinity Technologies and Pictor, Inc. Partner to Develop and Commercialize bioAffinity's Diagnostics for Asthma and COPD Business Wire 8:08 AM

-- July 7, 2026 --

bioAffinity Technologies' Quarterly CyPath Lung Sales Double to New Record as Commercial Momentum Continues Business Wire 8:46 AM

-- June 22, 2026 --

bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells Business Wire 8:00 AM

-- June 18, 2026 --

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering PRNewswire 2:55 PM
bioAffinity Technologies Announces Closing of $3.2 Million Offering Business Wire 1:16 PM

-- June 17, 2026 --

WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering PRNewswire 10:42 AM
bioAffinity Technologies Announces Pricing of $3.2 Million Offering Business Wire 9:25 AM

-- June 16, 2026 --

bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans Business Wire 8:06 AM

-- June 2, 2026 --

Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies' Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar Business Wire 8:00 AM

-- May 27, 2026 --

bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath Lung Technology Business Wire 8:00 AM

-- May 12, 2026 --

bioAffinity Technologies Reports Record Monthly CyPath Lung Unit Sales and Significant Year-Over-Year Growth in April 2026 Business Wire 9:15 AM

-- May 8, 2026 --

bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath Lung Business Wire 8:30 AM

-- April 28, 2026 --

bioAffinity Technologies Launches New Study To Expand Use of CyPath Lung Technology for Asthma and COPD Diagnosis and Treatment Business Wire 9:16 AM

-- April 14, 2026 --

New Case Study: bioAffinity Technologies' CyPath Lung Diagnostic Supports Physician's Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy Business Wire 8:00 AM
Market Data Delayed 15 Minutes